Form D · Other Technology
CELLCONTROL, INC.
Lisle, IL · CIK 0001809510
Offering snapshot reported Jul 9, 2020 · SEC filing
- Reported sold
- $6M Offering amount: $6M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $250K Reported outside-investor minimum
- First sale
- Jun 25, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 9, 2020 | Initial | $6,000,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-370639
Source: Form D, filed Jul 9, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph Boyle | Director, Executive |
| Joseph Breaux | Executive |
| J. Terrell Brown, Jr. | Director |
| Steven Chang | Director |
| Andrew Flett | Director |
| Alex Guira | Director |
| Jonathan Lieberman | Executive |
| John Nannenhorn | Executive |
| Dirk Schmuecking | Director |
| James Travers | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
1011 Warrenville Road Suite 210
Lisle, IL, 60606
Lisle, IL, 60606